PROCEPT BioRobotics (PRCT) Financial Statements
PROCEPT BioRobotics Financial Overview
PROCEPT BioRobotics's market cap is currently $20.66B. The company's EPS TTM is $-1.94; its P/E ratio is -9.90; PROCEPT BioRobotics is estimated to report earnings on November 4, 2026, and the estimated EPS forecast is $-7.37. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 308.05M | $ 224.50M | $ 136.19M | $ 75.01M | $ 34.47M |
| Gross Profit | $ 196.23M | $ 137.10M | $ 71.05M | $ 37.09M | $ 15.87M |
| Operating Income | $ -103.86M | $ -96.61M | $ -109.17M | $ -80.72M | $ -54.16M |
| EBITDA | $ -85.41M | $ -82.00M | $ -98.09M | $ -79.13M | $ -50.72M |
| Net Income | $ -95.57M | $ -91.41M | $ -105.90M | $ -87.15M | $ -59.85M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 286.50M | $ 333.73M | $ 257.22M | $ 222.64M | $ 304.32M |
| Total Assets | $ 508.08M | $ 534.02M | $ 404.72M | $ 309.33M | $ 337.02M |
| Total Debt | $ 78.48M | $ 80.25M | $ 79.20M | $ 77.32M | $ 54.10M |
| Net Debt | $ -208.02M | $ -253.47M | $ -178.02M | $ -145.32M | $ -250.22M |
| Total Liabilities | $ 142.21M | $ 131.80M | $ 123.97M | $ 112.26M | $ 69.93M |
| Stockholders' Equity | $ 365.87M | $ 402.22M | $ 280.75M | $ 197.07M | $ 267.09M |
| Cash Flow | |||||
| Free Cash Flow | $ -58.34M | $ -103.62M | $ -133.21M | $ -83.03M | $ -57.93M |
| Operating Cash Flow | $ -48.98M | $ -99.21M | $ -108.00M | $ -80.38M | $ -57.33M |
| Investing Cash Flow | $ -9.36M | $ -4.41M | $ -25.21M | $ -2.65M | $ -592.00K |
| Financing Cash Flow | $ 11.19M | $ 180.13M | $ 167.79M | $ 3.61M | $ 262.12M |
Currency in USD
